Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1868 1
1936 1
1938 1
1939 1
1940 3
1946 2
1947 3
1948 7
1949 3
1950 9
1951 12
1952 4
1953 3
1954 5
1955 3
1956 3
1957 1
1958 2
1959 1
1963 1
1964 1
1965 1
1966 4
1968 3
1969 5
1970 4
1971 7
1972 2
1973 6
1974 2
1975 6
1976 17
1977 17
1978 9
1979 8
1980 10
1981 8
1982 10
1983 13
1984 11
1985 10
1986 11
1987 9
1988 8
1989 15
1990 8
1991 17
1992 5
1993 8
1994 11
1995 13
1996 10
1997 14
1998 15
1999 18
2000 14
2001 22
2002 23
2003 27
2004 27
2005 19
2006 29
2007 41
2008 30
2009 33
2010 22
2011 35
2012 27
2013 34
2014 36
2015 33
2016 40
2017 44
2018 40
2019 46
2020 52
2021 69
2022 43
Text availability
Article attribute
Article type
Publication date

Search Results

1,083 results
Results by year
Filters applied: . Clear all
Page 1
Neutralising antibody activity against SARS-CoV-2 VOCs B.1.617.2 and B.1.351 by BNT162b2 vaccination.
Wall EC, Wu M, Harvey R, Kelly G, Warchal S, Sawyer C, Daniels R, Hobson P, Hatipoglu E, Ngai Y, Hussain S, Nicod J, Goldstone R, Ambrose K, Hindmarsh S, Beale R, Riddell A, Gamblin S, Howell M, Kassiotis G, Libri V, Williams B, Swanton C, Gandhi S, Bauer DL. Wall EC, et al. Among authors: kelly g. Lancet. 2021 Jun 19;397(10292):2331-2333. doi: 10.1016/S0140-6736(21)01290-3. Epub 2021 Jun 3. Lancet. 2021. PMID: 34090624 Free PMC article. No abstract available.
Quercetin. Monograph.
Kelly GS. Kelly GS. Altern Med Rev. 2011 Jun;16(2):172-94. Altern Med Rev. 2011. PMID: 21649459 Review. No abstract available.
Tumor-Suppressor Functions of the TP53 Pathway.
Aubrey BJ, Strasser A, Kelly GL. Aubrey BJ, et al. Among authors: kelly gl. Cold Spring Harb Perspect Med. 2016 May 2;6(5):a026062. doi: 10.1101/cshperspect.a026062. Cold Spring Harb Perspect Med. 2016. PMID: 27141080 Free PMC article. Review.
AZD1222-induced neutralising antibody activity against SARS-CoV-2 Delta VOC.
Wall EC, Wu M, Harvey R, Kelly G, Warchal S, Sawyer C, Daniels R, Adams L, Hobson P, Hatipoglu E, Ngai Y, Hussain S, Ambrose K, Hindmarsh S, Beale R, Riddell A, Gamblin S, Howell M, Kassiotis G, Libri V, Williams B, Swanton C, Gandhi S, Bauer DL. Wall EC, et al. Among authors: kelly g. Lancet. 2021 Jul 17;398(10296):207-209. doi: 10.1016/S0140-6736(21)01462-8. Epub 2021 Jun 28. Lancet. 2021. PMID: 34197809 Free PMC article. No abstract available.
A SARS-CoV-2 targeted siRNA-nanoparticle therapy for COVID-19.
Idris A, Davis A, Supramaniam A, Acharya D, Kelly G, Tayyar Y, West N, Zhang P, McMillan CLD, Soemardy C, Ray R, O'Meally D, Scott TA, McMillan NAJ, Morris KV. Idris A, et al. Among authors: kelly g. Mol Ther. 2021 Jul 7;29(7):2219-2226. doi: 10.1016/j.ymthe.2021.05.004. Epub 2021 May 14. Mol Ther. 2021. PMID: 33992805 Free PMC article.
Neutralising antibodies after COVID-19 vaccination in UK haemodialysis patients.
Carr EJ, Wu M, Harvey R, Wall EC, Kelly G, Hussain S, Howell M, Kassiotis G, Swanton C, Gandhi S, Bauer DL; Haemodialysis COVID-19 consortium; Crick COVID Immunity Pipeline, Billany RE, Graham-Brown MP, Beckett J, Bull K, Shankar S, Henderson S, Motallebzadeh R, Salama AD, Harper L, Mark PB, McAdoo S, Willicombe M, Beale R. Carr EJ, et al. Among authors: kelly g. Lancet. 2021 Sep 18;398(10305):1038-1041. doi: 10.1016/S0140-6736(21)01854-7. Epub 2021 Aug 13. Lancet. 2021. PMID: 34391504 Free PMC article. No abstract available.
1,083 results